GLP-1 receptor agonists are a transformative prehabilitation tool for weight loss in obese patients undergoing elective hernia repair
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
GLP-1 receptor agonists are a transformative prehabilitation tool for weight loss in obese patients undergoing elective hernia repair ; day:5 ; month:10 ; year:2024 ; pages:1-8
Surgical endoscopy and other interventional techniques ; (5.10.2024), 1-8
- Creator
-
Spurzem, Graham J.
Broderick, Ryan C.
Ruiz-Cota, Patricia
Hollandsworth, Hannah M.
Sandler, Bryan J.
Horgan, Santiago
Grunvald, Eduardo
Jacobsen, Garth R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00464-024-11308-6
- URN
-
urn:nbn:de:101:1-2412232107024.946824960064
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spurzem, Graham J.
- Broderick, Ryan C.
- Ruiz-Cota, Patricia
- Hollandsworth, Hannah M.
- Sandler, Bryan J.
- Horgan, Santiago
- Grunvald, Eduardo
- Jacobsen, Garth R.
- SpringerLink (Online service)
Other Objects (12)
Prehabilitation in elective surgical interventions – what must the general and abdominal surgeon know
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Prehabilitation in elective surgical interventions – what must the general and abdominal surgeon know
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Prehabilitation in elective surgical interventions – what must the general and abdominal surgeon know
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models